The verdictThe March 2026 recapitalisation bought i-80 time, not safety. This run's numbers show cash burn of about $186M a year against about $415M of Lone Tree spend still to come, so Phase 1 needs the accordion and the in-the-money warrant cash. The plan also leaves a revenue gap in H2 2027, just before 39,978 oz of prepay deliveries start in January 2028. The evidence leans to "real asset, unproven timetable". The…
Written by Claude (Anthropic’s AI) from public sources · Willem owns IAUX · AI can make mistakes — numbers in brackets point to the sources · Not financial advice
Bull arguments show how well they survive the devil’s advocate (strong / medium / weak); bear arguments show the damage they could do after the counter-argument (high / medium / low).
The point: "Fully funded for all three phases, with no further equity being required" [29] does not survive the arithmetic.
Evidence:
Quarterly free cash flow (operating cash flow minus capex) worsened through the year [1,2,12]:
| Quarter | Free cash flow |
|---|---|
| Q3-25 | −$18.5M |
| Q4-25 | −$39.2M |
| Q1-26 | −$57.0M |
| Q2-26 | −$71.1M |
Operating cash flow alone was −$49.6M in Q2, even before most Lone Tree spending [1].
Lone Tree still had more than $400M to spend after 6/30, and the 10-Q says spend is "weighted in the second half" [1].
Funding check from 6/30/26 to end-2027 (estimate):
| Item | Amount | |
|---|---|---|
| Uses | Operating burn | ~$270–300M |
| Lone Tree | ~$415M | |
| Other growth capex | ~$30M | |
| Convertible coupons | ~$16M | |
| Total uses | ~$730–760M | |
| Sources | Cash | $465M |
| US$0.70 warrants, if exercised | ~$106M | |
| Accordion | $100M | |
| Franco-Nevada tranche | $25M | |
| Auramet line (may lapse around 2026-10) | $12M | |
| Total sources | ~$708M |
The COO said labour costs run "5–10% over budget" (Mining Forum Americas, 2026-09-29, AI transcript with low reliability) [29].
Why it matters: Interpretation: Phase 1 works only if three things happen:
The last of these depends on the stock staying above $0.70, which is likely. Any overrun on Lone Tree, which has no published contingency figure, or a slower ramp-up, means a new stream, royalty or equity before first gold.
🛡️ Counter-argument:
Severity: High. It is not a 2026 problem, but the margin for error through 2027 is about one quarter of burn.
Consensus caveat: no clean consensus is available. The FY2028 figures used below are about $622M revenue (1 analyst, Simply Wall St) and EPS of about C$0.26 ≈ US$0.19 (4 analysts, Stocksguide) [28]. Both are low confidence. Share base for FY2028 is about 1.02B, which assumes the US$0.70 warrants are exercised. A 20% tax rate is assumed (estimate).
Gold averages ~$4,150+ in 2028, above the ~$3,550 deck consensus appears to use — 60% chance by end-2028
Lone Tree sells spare autoclave capacity to third parties — 10% chance within 36 months
Mineral Point PFS converts ~5 Moz into reserves — 35% chance by end-2027
A takeover bid — 10% chance within 36 months
Lone Tree first pour slips two quarters or more into 2028 — 40% chance by end-2028
Opex 15% above study costs — 45% chance by FY2028
Lone Tree ramps slowly or recovers ~80% instead of 87% — 35% chance in FY2028
Gold averages ~$3,000 in 2028 — 15% chance by end-2028
New equity or stream before first gold — 30% chance by end-2027
Nevada raises mining taxes in the 2027 session — 6% chance by end-2027
| # | Factor | Weight | Measured value | Score | Why |
|---|---|---|---|---|---|
| 1 | Liquidity & funding runway | 15% | Cash $464.6M; TTM FCF −$185.8M (Q2 −$71.1M); runway |
68 | Runway is 12–36 months, and the funding check to end-2027 needs the accordion and warrant cash. Kept below 75 by the absence of maturities and going-concern language. |
| 2 | Leverage | 10% | Debt $445.7M vs cash $464.6M (net cash ~$19M at 6/30); EBITDA negative; prepay 13.5% with first lien; no maturity before 2031 | 58 | Net cash today, but large debt against negative EBITDA, and the net position turns to net debt as Lone Tree spending runs. |
| 3 | Dilution | 10% | Shares +6.1% y/y (816.0M→865.9M); overhang ~374M (196M warrants, 149M convert shares, ~29M awards) ≈ 43% | 62 | Realised dilution is in the 3–10% band. The overhang, including ~152M US$0.70 warrants that will almost surely be exercised (+17.5%), pushes it up a band. |
| 4 | Profitability | 10% | TTM revenue $130.0M; gross margin 25%; FCF margin −143%; Q2 operating margin −140% | 80 | Deep losses while building. Positive gross margin on the Granite Creek ore stops it reaching the top of the scale. |
| 5 | Revenue quality & concentration | 10% | One producing mine; one processor (NGM) for all refractory ore; top customer 66% of H1 revenue, top 3 96% | 76 | A single asset and a single processor. The commodity itself can be sold to anyone, so it is not the maximum. |
| 6 | Execution & track record | 10% | Cove study slipped 4 times, Granite Creek 3, Archimedes 2; 2025 production at the bottom of guidance; Lone Tree $400M→$430M; recap early; no material weakness | 70 | Frequent date misses, with the costly items (budget, recap) held so far. |
| 7 | Competitive position & disruption | 10% | Price taker; one of two autoclave owners in Nevada; life-of-mine AISC $2,273/oz | 45 | A scarce processing asset once it runs, but small and high-cost today. |
| 8 | Cyclicality & commodity sensitivity | 10% | ~100% gold (silver streamed); Granite Creek NPV $41M at $2,500 vs $467M at $4,000; GDXJ −61% in 2013 | 74 | A one-commodity, high-cost developer whose funding plan needs a supportive gold equity market. |
| 9 | Regulatory, legal & geopolitical | 5% | Lone Tree air, mercury, water pollution control and reclamation permits outstanding; 3 projects need an EIS; no material litigation; US-only | 48 | Material and on the critical path, but in a top jurisdiction. |
| 10 | Valuation & expectations | 10% | $1.59; EV ~$1.35B ≈ $208/oz M&I; mean target $2.99; short interest 93.9M (10.8%, 9.7 days) partly convert hedge; 2027 consensus looks front-loaded | 45 | Not demanding on assets, but near-term estimates look too high and short interest is meaningful. |
Overall: weighted average = 10.20 + 5.80 + 6.20 + 8.00 + 7.60 + 7.00 + 4.50 + 7.40 + 2.40 + 4.50 = 63.6 → 64.
Change vs last: +3 vs 61 on the old 6-area method. This is not like-for-like. The new method scores liquidity on its own (68), and this run's quarterly free-cash-flow series and funding check made liquidity look tighter than "cash > debt" suggested. Profitability (80) is now scored explicitly. On the other side, finding NGM as the processor and the mid-2027 stockpiling plan soften the toll-cliff element of the old "Dependency" score.
Ranking check: IAUX (64) sits between EROC (58) and DUOT (66). It burns more cash relative to revenue and relies on one plant restart, unlike EROC, which already has contracted revenue. It ranks below DUOT and IPX because it has producing ounces, $465M in cash and no single-tenant dependency.